Subo, Ramon L.
HRN: 13-46-19 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/19/2023
CEFTRIAXONE 1G (VIAL)
06/19/2023
06/26/2023
IV
2 Grams
OD
TBI
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueCentral Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes